The Genome Reset
How GHK-Cu modulates 32% of human genes and reverses disease signatures
Rewriting the Genetic Playbook
In 2014, researchers documented what may be GHK-Cu's most remarkable property: it modulates the expression of 32.1% of human genes -- over 4,000 genes in total. Using the Broad Institute's Connectivity Map, scientists discovered that this tiny tripeptide can reverse disease-associated gene expression patterns, from metastatic colon cancer to COPD.
The Connectivity Map
How the Broad Institute's tool revealed GHK-Cu's gene-level effects.
Scope of Modulation
The scale and significance of 4,000+ genes affected.
Gene Categories
Which gene families and pathways are most affected.
Cancer-Related Genes
How GHK-Cu shifts expression of cancer-associated gene signatures.
Disease Signature Reversal
Evidence for reversing COPD, tissue destruction, and other disease patterns.